U.S. Psychedelic Mushroom Market Size, Share & Trends Analysis Report By Product (Psilocybe, Gymnopilus, Panaeolus), By Form (Fresh/Whole, Dried, Processed), By Application, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 4 Business Days
U.S. Psychedelic Mushroom Market Growth & Trends
The U.S. psychedelic mushroom market size is expected treach USD 4.32 billion by 2030, growing at a CAGR of 11.5% from 2025 t2030, according ta new report by Grand View Research, Inc. The use of psychedelic mushrooms and other plant-based entheogens is gaining acceptance in the U.S., with a growing movement tdecriminalize their use. Several cities and states have taken steps tlegalize or decriminalize these substances, leading ta surge in interest and demand.
Psychedelic mushrooms have shown promising results in treating various mental health conditions such as depression, anxiety, PTSD, and addiction. As further research is conducted on their therapeutic potential, demand for these substances is likely tincrease.
The primary application of psychedelic mushrooms is in the treatment of depression and anxiety disorders. Psilocybin, the active ingredient in these mushrooms, has been found talleviate symptoms of depression and anxiety and even induce long-term positive changes in personality and behavior. This has sparked growing interest in the use of psilocybin as a potential treatment for other mental health conditions such as PTSD, addiction, and end-of-life anxiety in patients with terminal illnesses.
The growing awareness of mental health issues in the U.S. is a major factor driving the demand for psychedelic mushrooms. Traditional treatments for depression, anxiety, and other mental health conditions may not work for everyone, prompting many individuals tseek out alternative therapies, such as psychedelic therapy.
Moreover, there is an increasing interest in natural and plant-based remedies, as people become more aware of the potential risks and side effects of synthetic drugs. Psilocybin, the natural psychoactive compound found in psychedelic mushrooms, has been used for centuries by indigenous cultures for spiritual and therapeutic purposes. As the interest in natural and alternative therapies grows, the demand for psychedelic mushrooms is expected tcontinue increasing.
Psychedelic mushrooms alsoffer a potential treatment for cluster headaches, which are severe and often resistant ttraditional treatments. Psilocybin has demonstrated effectiveness in reducing the frequency and severity of cluster headaches in some patients, offering new hope for individuals whsuffer from this debilitating condition.
U.S. Psychedelic Mushroom Market Report Highlights
U.S. Psychedelic Mushroom Market Growth & Trends
The U.S. psychedelic mushroom market size is expected treach USD 4.32 billion by 2030, growing at a CAGR of 11.5% from 2025 t2030, according ta new report by Grand View Research, Inc. The use of psychedelic mushrooms and other plant-based entheogens is gaining acceptance in the U.S., with a growing movement tdecriminalize their use. Several cities and states have taken steps tlegalize or decriminalize these substances, leading ta surge in interest and demand.
Psychedelic mushrooms have shown promising results in treating various mental health conditions such as depression, anxiety, PTSD, and addiction. As further research is conducted on their therapeutic potential, demand for these substances is likely tincrease.
The primary application of psychedelic mushrooms is in the treatment of depression and anxiety disorders. Psilocybin, the active ingredient in these mushrooms, has been found talleviate symptoms of depression and anxiety and even induce long-term positive changes in personality and behavior. This has sparked growing interest in the use of psilocybin as a potential treatment for other mental health conditions such as PTSD, addiction, and end-of-life anxiety in patients with terminal illnesses.
The growing awareness of mental health issues in the U.S. is a major factor driving the demand for psychedelic mushrooms. Traditional treatments for depression, anxiety, and other mental health conditions may not work for everyone, prompting many individuals tseek out alternative therapies, such as psychedelic therapy.
Moreover, there is an increasing interest in natural and plant-based remedies, as people become more aware of the potential risks and side effects of synthetic drugs. Psilocybin, the natural psychoactive compound found in psychedelic mushrooms, has been used for centuries by indigenous cultures for spiritual and therapeutic purposes. As the interest in natural and alternative therapies grows, the demand for psychedelic mushrooms is expected tcontinue increasing.
Psychedelic mushrooms alsoffer a potential treatment for cluster headaches, which are severe and often resistant ttraditional treatments. Psilocybin has demonstrated effectiveness in reducing the frequency and severity of cluster headaches in some patients, offering new hope for individuals whsuffer from this debilitating condition.
U.S. Psychedelic Mushroom Market Report Highlights
- The psilocybe product segment led the market in terms of revenue in 2024, owing tincreasing research inttheir therapeutic potential and a growing trend towards natural and holistic health practices.
- The processed form segment is expected tgrow at a CAGR of 12.2% over the forecast period, owing teasier tconsume than dried mushrooms and more consistent dose of psilocybin.
- The de-addiction application segment is expected tgrow at a CAGR of 12.3% from 2025 t2030. As psilocybin, found in psychedelic mushrooms, is a potential treatment for substance abuse when paired with therapy.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Regional Outlook
CHAPTER 3. U.S. PSYCHEDELIC MUSHROOM MARKET VARIABLES & TRENDS
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Suppliers Outlook
3.2.3. Manufacturing and Technology Trends
3.2.4. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Challenges
3.3.4. Market Opportunities
3.4. Industry Analysis – Porter’s Five Force Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Service Provider Adoption
4.5. Key Observations & Findings
CHAPTER 5. U.S. PSYCHEDELIC MUSHROOM MARKET: PRODUCT ANALYSIS & ESTIMATES
5.1. Product Movement Analysis & Market Share, 2024 & 2030
5.2. Psilocybe
5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.2. Cubensis
5.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.3. Semilanceata
5.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.4. Azurescens
5.2.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.5. Cyanescens
5.2.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.6. Baeocystis
5.2.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.7. Others
5.2.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3. Gymnopilus
5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Spectabilis
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Others
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4. Panaeolus
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. PSYCHEDELIC MUSHROOM MARKET: APPLICATION ANALYSIS & ESTIMATES
6.1. Application Movement Analysis & Market Share, 2024 & 2030
6.1.1. Depression Relief
6.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.2. Anxiety Relief
6.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.3. Deaddiction
6.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.4. Recreational
6.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.5. Others
6.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. PSYCHEDELIC MUSHROOM MARKET: FORM ANALYSIS & ESTIMATES
7.1. Form Movement Analysis & Market Share, 2024 & 2030
7.2. Fresh/Whole
7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3. Dried
7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Processed
7.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. U.S. PSYCHEDELIC MUSHROOM MARKET: COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (% )
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. List of key companies analyzed in this section includes:
8.9.1. Compass Pathways
8.9.2. Field Trip Health
8.9.3. Cybin Inc.
8.9.4. Seelos Therapeutics
8.9.5. Numinus Wellness
8.9.6. Galaxy Treats
8.9.7. Blissmushrooms
8.9.8. Atai Life Sciences
8.9.9. Berma
8.9.10. PharmaTher
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Regional Outlook
CHAPTER 3. U.S. PSYCHEDELIC MUSHROOM MARKET VARIABLES & TRENDS
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Suppliers Outlook
3.2.3. Manufacturing and Technology Trends
3.2.4. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Challenges
3.3.4. Market Opportunities
3.4. Industry Analysis – Porter’s Five Force Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Service Provider Adoption
4.5. Key Observations & Findings
CHAPTER 5. U.S. PSYCHEDELIC MUSHROOM MARKET: PRODUCT ANALYSIS & ESTIMATES
5.1. Product Movement Analysis & Market Share, 2024 & 2030
5.2. Psilocybe
5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.2. Cubensis
5.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.3. Semilanceata
5.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.4. Azurescens
5.2.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.5. Cyanescens
5.2.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.6. Baeocystis
5.2.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.7. Others
5.2.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3. Gymnopilus
5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Spectabilis
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Others
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4. Panaeolus
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. PSYCHEDELIC MUSHROOM MARKET: APPLICATION ANALYSIS & ESTIMATES
6.1. Application Movement Analysis & Market Share, 2024 & 2030
6.1.1. Depression Relief
6.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.2. Anxiety Relief
6.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.3. Deaddiction
6.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.4. Recreational
6.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.1.5. Others
6.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. PSYCHEDELIC MUSHROOM MARKET: FORM ANALYSIS & ESTIMATES
7.1. Form Movement Analysis & Market Share, 2024 & 2030
7.2. Fresh/Whole
7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3. Dried
7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Processed
7.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. U.S. PSYCHEDELIC MUSHROOM MARKET: COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (% )
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. List of key companies analyzed in this section includes:
8.9.1. Compass Pathways
8.9.2. Field Trip Health
8.9.3. Cybin Inc.
8.9.4. Seelos Therapeutics
8.9.5. Numinus Wellness
8.9.6. Galaxy Treats
8.9.7. Blissmushrooms
8.9.8. Atai Life Sciences
8.9.9. Berma
8.9.10. PharmaTher
